abstract |
The present invention relates to compounds of formula (I) which are inhibitors of factor Xa and pharmaceutically acceptable salts, esters and prodrugs thereof. The invention also relates to intermediates used to prepare such compounds, pharmaceutical compositions containing such compounds, methods of preventing or treating a number of conditions characterized by undesirable thrombosis and methods of inhibiting coagulation of blood samples. |